用于治疗精神分裂症的植物性多化合物:机制和治疗潜力
Xiaolin Ji1, Jianbo Chai2, Sihan Zhao2
1The Second Clinical Medical College, Heilongjiang University of Chinese Medicine, Harbin, China.
Frontiers in pharmacology
|July 4, 2025
概括
植物多,如黄素和EGCG,通过减少炎症和改善大脑功能,对精神分裂症产生神经保护作用. 这些天然化合物为传统疗法提供了有希望的替代品,副作用较少.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 自然产品化学 自然产品化学
背景情况:
- 精神分裂症是一种严重的精神障碍,导致严重的社会耻辱和功能障碍.
- 目前用于治疗精神分裂症的药理疗法往往具有局限性和不良影响.
- 植物性多,如黄素和表甲基酸盐 (EGCG),正在研究它们的治疗潜力.
研究的目的:
- 在精神分裂症的背景下探索植物性多的生物活动和神经保护机制.
- 评估聚醇作为精神分裂症的替代治疗剂的潜力,重点关注症状缓解和认知增强.
主要方法:
- 审查关于黄素,EGCG和其他植物多的神经保护性质的现有研究.
- 分析机制,包括抗氧化和抗炎作用,神经递质调节,线粒体功能和神经发生.
- 检查动物研究表明多醇对来自大脑的神经营养因子 (BDNF),ATP水平,抗氧化酶 (SOD),炎症标志物 (IL-6) 和神经递质 (多巴胺,谷氨酸) 的影响.
主要成果:
- 黄素和EGCG通过抗氧化,抗炎和神经生成刺激途径表现出神经保护作用.
- 聚醇增强线粒体功能,增加BDNF水平,并改善抗氧化能力 (减少MDA,增加SOD活性).
- 这些化合物调节神经递质 (多巴胺,谷氨酸) 并减少炎症 (IL-6),显示出对精神分裂症症状管理的潜力.
结论:
- 植物性聚醇为治疗精神分裂症症状和改善认知功能提供了一个有希望的低毒性替代品.
- 它们的多目标机制与向全面网络调节疗法的转变保持一致.
- 交付策略的进步,比如纳米技术,增强了这些天然衍生物的潜力.
更多相关视频
12:00Extraction and Purification of Polyphenols from Freeze-dried Berry Powder for the Treatment of Vascular Smooth Muscle Cells In Vitro
Published on: July 5, 2017
19.3K
14:39Semi-Targeted Ultra-High-Performance Chromatography Coupled to Mass Spectrometry Analysis of Phenolic Metabolites in Plasma of Elderly Adults
Published on: April 22, 2022
4.0K
相关概念视频
01:28Psychosis and Antipsychotic Drugs: Overview
465
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
465
01:26Psychosis: Goals of Pharmacotherapy
213
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
213
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
999
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
999
01:28Drug Therapy
107
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
107
01:29Biological Causes of Schizophrenia
152
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
152
01:21Antipsychotic Drugs: Therapeutic Uses and Side Effects
392
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
392